JP2019043957A5 - - Google Patents

Download PDF

Info

Publication number
JP2019043957A5
JP2019043957A5 JP2018210606A JP2018210606A JP2019043957A5 JP 2019043957 A5 JP2019043957 A5 JP 2019043957A5 JP 2018210606 A JP2018210606 A JP 2018210606A JP 2018210606 A JP2018210606 A JP 2018210606A JP 2019043957 A5 JP2019043957 A5 JP 2019043957A5
Authority
JP
Japan
Prior art keywords
formula
group
compound
independently
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018210606A
Other languages
English (en)
Japanese (ja)
Other versions
JP6767459B2 (ja
JP2019043957A (ja
Filing date
Publication date
Priority claimed from GBGB1315335.8A external-priority patent/GB201315335D0/en
Application filed filed Critical
Publication of JP2019043957A publication Critical patent/JP2019043957A/ja
Publication of JP2019043957A5 publication Critical patent/JP2019043957A5/ja
Application granted granted Critical
Publication of JP6767459B2 publication Critical patent/JP6767459B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018210606A 2013-08-29 2018-11-08 アミノ二酸含有ペプチド修飾剤 Active JP6767459B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1315335.8 2013-08-29
GBGB1315335.8A GB201315335D0 (en) 2013-08-29 2013-08-29 Amino diacids containing peptide modifiers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016537416A Division JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤

Publications (3)

Publication Number Publication Date
JP2019043957A JP2019043957A (ja) 2019-03-22
JP2019043957A5 true JP2019043957A5 (https=) 2019-05-09
JP6767459B2 JP6767459B2 (ja) 2020-10-14

Family

ID=49356024

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016537416A Pending JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤
JP2018210606A Active JP6767459B2 (ja) 2013-08-29 2018-11-08 アミノ二酸含有ペプチド修飾剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016537416A Pending JP2016532705A (ja) 2013-08-29 2014-08-28 アミノ二酸含有ペプチド修飾剤

Country Status (10)

Country Link
US (3) US20160207957A1 (https=)
EP (2) EP3725801A3 (https=)
JP (2) JP2016532705A (https=)
KR (1) KR102461744B1 (https=)
CN (2) CN105683156A (https=)
AU (2) AU2014313779B2 (https=)
CA (1) CA2922220C (https=)
ES (1) ES2831974T3 (https=)
GB (1) GB201315335D0 (https=)
WO (1) WO2015028966A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
US11117946B2 (en) 2016-03-23 2021-09-14 Bachem Holding Ag Method for preparing glucagon-like peptides
US11338018B2 (en) 2016-12-19 2022-05-24 Harrow Ip, Llc Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
CN110294800B (zh) * 2018-03-22 2022-03-04 齐鲁制药有限公司 一种索玛鲁肽的制备方法
CA3108931C (en) * 2018-08-09 2023-11-07 F. Hoffmann-La Roche Ag Cleavable linker for peptide synthesis
CN112912390B (zh) 2018-10-09 2023-12-15 北京费森尤斯卡比医药有限公司 Glp-1类似物的制备方法
GB201816639D0 (en) * 2018-10-12 2018-11-28 Heptares Therapeutics Ltd GLP-1 Receptor Antagonist
WO2020150262A1 (en) * 2019-01-17 2020-07-23 Harrow Ip, Llc Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof
CN109776323B (zh) * 2019-01-28 2022-05-17 富乐马鸿凯（大连）医药有限公司 一种高效选择性制备脂肪二酸单叔丁酯的方法
WO2020208409A1 (en) * 2019-04-10 2020-10-15 Dr. Reddy’S Laboratories Limited Improved processes for the preparation of peptide intermediates/modifiers
CN110372785B (zh) * 2019-07-25 2020-10-23 成都诺和晟泰生物科技有限公司 一种索马鲁肽的合成方法
CN111269137A (zh) * 2020-01-16 2020-06-12 浙江工业大学 一种液相法制备索马鲁肽侧链的方法
CN111285780A (zh) * 2020-01-16 2020-06-16 浙江工业大学 索马鲁肽侧链的汇聚式液相合成法
CN111253287A (zh) * 2020-01-16 2020-06-09 浙江工业大学 液相汇聚式合成索马鲁肽侧链的方法
CN115884982A (zh) 2020-03-06 2023-03-31 赛诺菲 作为选择性gip受体激动剂的肽
JP7832927B2 (ja) 2020-08-19 2026-03-18 サノフイ Ｃｒｆ２受容体アゴニスト及び治療におけるその使用
EP4399224A1 (en) 2021-09-06 2024-07-17 Sanofi New peptides as potent and selective gip receptor agonists
CN115504893B (zh) * 2022-11-18 2023-03-10 成都普康生物科技有限公司 一种L-谷氨酸-α-叔丁酯的合成方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
CA2324348C (en) 1998-03-23 2006-03-14 Trimeris, Inc. Methods and compositions for peptide synthesis
US6716963B1 (en) * 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
GB9812675D0 (en) 1998-06-11 1998-08-12 Univ Edinburgh Peptides
DE19924606A1 (de) * 1999-05-28 2000-11-30 Graffinity Pharm Design Gmbh Ligand-Anker-Konjugate
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
WO2001036003A2 (en) * 1999-11-15 2001-05-25 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US6621548B2 (en) 2001-06-15 2003-09-16 Viztec, Inc. Electrooptical displays constructed with polymer-coated elements positioned between substrates
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
IL161446A0 (en) 2001-11-26 2004-09-27 Daiichi Suntory Pharma Co Ltd Medicinal compositions for nasal absorption
EP1504022B1 (en) 2002-05-03 2006-10-11 Avecia Limited Process for the synthesis of peptide amides by side-chain attachment to a solid phase
CA2851462A1 (en) 2003-01-08 2004-07-29 University Of Washington Antibacterial agents
US20040142379A1 (en) * 2003-01-16 2004-07-22 Carlsberg Research Laboratory Affinity fishing for ligands and proteins receptors
MXPA06001283A (es) 2003-08-05 2006-04-11 Novo Nordisk As Derivados de insulina novedosos.
CN1902226A (zh) 2003-12-03 2007-01-24 诺和诺德公司 单链胰岛素
EP3075247B1 (en) * 2004-02-02 2022-10-12 BioSight Ltd. Conjugates for cancer therapy and diagnosis
WO2005082404A2 (en) * 2004-02-27 2005-09-09 Novo Nordisk A/S Glp-2 derivatives modified by lipophilic substituents
US7893017B2 (en) 2004-10-07 2011-02-22 Novo Nordisk A/S Protracted GLP-1 compounds
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
US7560588B2 (en) * 2006-04-27 2009-07-14 Intezyne Technologies, Inc. Poly(ethylene glycol) containing chemically disparate endgroups
AU2007304427A1 (en) 2006-10-05 2008-04-10 Lonza Ag Method for peptide synthesis
KR101046846B1 (ko) 2006-10-12 2011-07-06 동국제약 주식회사 고체상 합성법을 이용한 펩타이드의 제조방법
EP2178910B1 (en) 2007-08-15 2014-10-08 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
FR2921831B1 (fr) * 2007-10-05 2014-05-09 Oreal Composition cosmetique ou dermatologique comprenant un polymere portant des groupes de jonction, et procede de traitement cosmetique
CN102026671B (zh) * 2008-03-14 2014-09-03 Visen医药公司 整联蛋白靶向试剂及使用其的体内和体外成像方法
CN102037008B (zh) * 2008-03-18 2016-08-31 诺沃-诺迪斯克有限公司 蛋白酶稳定化的、酰化胰岛素类似物
US8637647B2 (en) 2008-09-12 2014-01-28 Novo Nordisk A/S Method of acylating a peptide or protein
WO2010052144A2 (en) * 2008-11-05 2010-05-14 F. Hoffmann-La Roche Ag Neuropeptide-2-receptor (y-2r) agonists and uses thereof
US8685919B2 (en) * 2008-12-15 2014-04-01 Zealand Pharma A/S Glucagon analogues
EP2413937A1 (en) 2009-04-02 2012-02-08 Shire LLC Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
AP3329A (en) 2009-07-13 2015-06-30 Zealand Pharma As Acylated glucagon analogues
IN2012DN03042A (https=) 2009-10-13 2015-07-31 Hoffmann La Roche
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
CN118767117A (zh) 2010-01-22 2024-10-15 诺沃—诺迪斯克保健股份有限公司 体内功效延长的生长激素
EP2552950A1 (en) * 2010-03-26 2013-02-06 Novo Nordisk A/S Novel glucagon analogues
PH12012502472A1 (en) 2010-06-24 2013-03-25 Zealand Pharma As Glucagon analogues
CN105037278B (zh) * 2010-07-07 2019-05-03 康奈尔大学 Sirt5调节剂及其筛选方法
JP2013209295A (ja) * 2010-10-13 2013-10-10 Takeda Chem Ind Ltd ペプチド誘導体
EP2652134B1 (en) * 2010-12-17 2017-03-01 Arrowhead Pharmaceuticals, Inc. Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
CN103403553B (zh) * 2010-12-22 2016-03-09 康奈尔大学 Sirt6的调节物及其筛选分析
CN102286092B (zh) 2011-09-14 2014-01-01 深圳翰宇药业股份有限公司 利拉鲁肽的固相合成方法
CN104011070A (zh) 2011-12-15 2014-08-27 爱德迪安（北京）生物技术有限公司 具有降血糖作用的化合物、组合物及其用途
WO2013092703A2 (en) * 2011-12-23 2013-06-27 Zealand Pharma A/S Glucagon analogues
CN102584944B (zh) 2012-02-06 2014-12-17 成都圣诺生物科技股份有限公司 一种依非巴特的制备方法
EP2664374A1 (en) * 2012-05-15 2013-11-20 F. Hoffmann-La Roche AG Lysin-glutamic acid dipeptide derivatives
CN102875665B (zh) * 2012-09-28 2014-11-26 深圳翰宇药业股份有限公司 一种合成利拉鲁肽的方法
CN103214568B (zh) * 2013-03-08 2014-09-24 深圳翰宇药业股份有限公司 一种固相制备促胰液素的方法
CN103242200A (zh) * 2013-04-10 2013-08-14 吉尔生化（上海）有限公司 一种Nα-芴甲氧羰基-Nε-乙酰基-赖氨酸的制备方法
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers

Similar Documents

Publication Publication Date Title
JP2019043957A5 (https=)
AU2018250226B2 (en) Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
JP6703668B2 (ja) ペプチド合成方法
JP2016153410A5 (https=)
JP6767459B2 (ja) アミノ二酸含有ペプチド修飾剤
TWI823054B (zh) IL-7Rα結合化合物
JP2022095872A5 (https=)
JP2011511778A5 (https=)
JP2020063241A5 (https=)
JP2021100937A5 (https=)
JP2015520184A5 (https=)
JP2015512910A (ja) ヒトｐｄ１のｂｃループに由来する免疫調節性環状化合物
JP2016505586A5 (https=)
JP2007500747A5 (https=)
JP2012512901A5 (https=)
JP2009532384A5 (https=)
JP6703669B2 (ja) リュープロレリンの製造方法
JP2014509838A5 (https=)
CN107001409A (zh) 疏水性肽的制造方法
JP2009500298A5 (https=)
JP2011530523A (ja) 酢酸グラチラマーの合成
JP2018505152A5 (https=)
JP2017518363A5 (https=)
JP2018521977A5 (https=)
JP7249591B2 (ja) 分解性ポリエチレングリコール結合体